Lipid, Apolipoprotein, and Lipoprotein Metabolism: Implications for the Diagnosis and Treatment of Dyslipidemia Oncohema Key Apolipoproteins: metabolic role and clinical biochemistry applications Marek H Dominiczak, Muriel J Caslake, 2011 Emerging Evidence that ApoC III Inhibitors Provide Novel Options to Reduce the Residual CVD Current Atherosclerosis Reports Springer Nature Link Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 ( Apolipoprotein C3) and ANGPTL3 (Angiopoietin Like Protein 3) Arteriosclerosis, Thrombosis, and Vascular Biology The Role of Apolipoproteins in the Commonest Cancers: A Review Reversibly reduced lipoprotein lipase in APOA5 c.553G>T related hypertriglyceridemia successfully treated with pemafibrate in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2026 Issue 1 (2026)